Current treatments for high-risk neuroblastoma are highly toxic and have achieved a survival rate of less than 40%. Despite this critical situation, obstacles such as the limited funding for research and the reluctance of pharmaceutical companies to pursue new therapies stand in the way of helping more kids survive this devastating cancer.

Our mission is to support funding for neuroblastoma research and treatment development in the hope that other families may be spared the loss that we have suffered.


See prize winners and photos from our March 1 event, Skate for Catherine!